Nymphomania is an outdated, gendered label for sexual desire judged excessive in women. Hypersexuality is a broader descriptive term; it does not automatically mean a disorder. Today, compulsive sexual behaviour disorder (CSBD) concerns a persistent difficulty controlling sexual behaviour that causes significant harm or impairment. A high libido alone does not meet that definition.
Original article by Taryn Cain. Adapted, updated and expanded by Brendan McDonald, Editor.
A word can sound medical and still carry a moral judgement. “Nymphomania” did both: it suggested a disease while leaving a rather important question unresolved. How much desire was too much, and who got to decide?
That question still matters. Someone worried about their sexual behaviour deserves a careful assessment. Someone whose desires offend other people deserves neither a diagnosis by insult nor a lecture disguised as healthcare. For disabled and chronically ill people, whose sexual lives may already be scrutinised or ignored, the distinction is especially consequential.
Nymphomania vs hypersexuality: what do the words mean?
In ordinary usage, a “nymphomaniac” means a woman perceived to want sex excessively. The shortened “nympho” is slang, often insulting or sexualising. Neither word gives a clinician a reliable account of a person's health.
Hypersexuality is less explicitly gendered, but it is not a precise replacement diagnosis. It has been used to describe unusually intense sexual interest, frequent sexual behaviour and patterns that feel difficult to control. Those experiences can overlap; they are not interchangeable.
| Term | What it tells you |
|---|---|
| Nymphomania | A historical label applied to supposedly excessive female sexuality. It carries assumptions about acceptable desire. |
| High libido | A strong interest in sex. By itself, it says nothing about loss of control or a mental disorder. |
| Hypersexuality | A broad description used in different ways. The speaker needs to explain which experiences or behaviours they mean. |
| CSBD | A diagnosis in the World Health Organization's ICD-11, with requirements involving impaired control, persistence and significant distress or impairment. |
“Sex addiction” is another term people may use to describe their experience or find support. The International Society for Sexual Medicine's 2024 expert review explains that ICD-11 places CSBD among impulse-control disorders. It is not formally classified there as an addictive disorder. DSM-5-TR, the American Psychiatric Association's diagnostic manual, does not include CSBD or the previously proposed hypersexual disorder.
The distinction is useful because a familiar name is not the same thing as an agreed explanation. People can need help even while researchers debate the best model for understanding their difficulties.
How nymphomania turned desire into a medical problem
In her original Wellcome Collection essay on nymphomania, Taryn Cain traced the uneasy relationship between ideas about female sexuality, social respectability and medical authority. The label offered apparent certainty about something deeply dependent on the expectations of its time.
The historical problem was larger than an unfortunate word. A diagnosis could make the boundary between acceptable and unacceptable womanhood look like a boundary between health and disease. Desire became suspect when it exceeded what others thought a woman should feel, express or pursue.
A historical analysis published in History of Psychiatry traces the formation of the category to the later seventeenth century. It examines Lazare Rivière's account of “madness from the womb”, explained at the time through supposed overheating and putrefaction of retained female seed. This was a theory embedded in a particular understanding of the body, not a description of the mechanisms recognised in current clinical guidance.
That left considerable power with the observer. A woman might be judged through her sexual behaviour, but also through the interpretation of that behaviour: too interested, too independent, too unwilling to stay within an assigned role. The label described the expectations surrounding her as well as anything about her.
Cain's account also describes attempts to regulate sexuality through medical treatment, including destructive interventions directed at women's bodies. This history should make us cautious about any approach that begins with an acceptable quantity of desire and then tries to force people beneath it.
We do not need to pretend every historical use meant exactly the same thing to recognise the pattern. Medical language can give cultural disapproval an authority it has not earned. Removing an old label is one step; changing the assumptions behind it takes more work.
Contemporary diagnostic criteria try to establish a different basis for assessment: what a person can control, what consequences they experience and whether another explanation fits better. That does not erase the history. It gives us a way to ask better questions.
When is sexual behaviour a clinical concern?
The WHO's current ICD-11 description of CSBD centres on a persistent failure to control intense, repetitive sexual urges or impulses, resulting in repetitive sexual behaviour. The pattern continues over an extended period, typically six months or more, and causes marked distress or significant impairment in important areas of life.
In practice, a clinician looks at the pattern and its consequences. Sexual activity may repeatedly displace health, personal care or responsibilities. Someone may have made numerous unsuccessful efforts to reduce the behaviour, continued despite serious consequences, or continued even when it brings little satisfaction. These are matters to explore in an assessment, not a scorecard for diagnosing yourself or a partner.
Frequency is not a diagnosis
A person can have a high sex drive, masturbate frequently or have multiple consensual partners without having CSBD. Equally, simply counting encounters can miss a pattern that is causing harm. The issue is how the behaviour functions in someone's life, not whether it exceeds someone else's preferred number.
The clinical explanation accompanying CSBD's introduction into ICD-11 explicitly warns against diagnosing people merely because they have high sexual interest. It also cautions against pathologising the sexual interest and behaviour common in adolescence.
Shame matters, but it does not settle the diagnosis
Distress that comes entirely from moral disapproval of sexual thoughts or behaviour is not sufficient for CSBD. A person might feel devastated about a consensual activity because it conflicts with their religious beliefs or with messages they absorbed about sex. That distress deserves care without assuming the activity itself is evidence of a disorder.
Shame and genuine difficulties with control can also coexist. A good assessment takes both seriously. It does not dismiss someone because they have conservative values, and it does not treat those values as a clinical test.
For example, a mismatch in desire between partners may need honest discussion about intimacy, boundaries and compatibility. It does not establish that the partner who wants more sex is ill. Repeated behaviour that someone cannot control and that is disrupting their health, work or relationships calls for a different conversation.
Unwanted thoughts are not the same as compulsive sexual behaviour
Intrusive sexual thoughts can occur in obsessive-compulsive disorder. Someone may be frightened by the thoughts, try to neutralise them or repeatedly check what they mean. The presence of sexual content does not make these experiences interchangeable with CSBD; the WHO's clinical guidance distinguishes the underlying patterns.
Miriam Swallow Adler's personal account of OCD and intrusive sexual thoughts describes how fear and shame can obstruct asking for help. It is a lived-experience essay with explicit language, rather than a diagnostic guide.
What is the male version of nymphomania?
The historical counterpart is satyriasis, a term used for supposedly excessive sexual desire in men. That answers the vocabulary question, but it should not become a new label to stick on someone.
Current assessment does not require separate “nymphomania” and “satyriasis” diagnoses. CSBD can be considered in people of any gender when its requirements are met. Gender stereotypes are a poor substitute for finding out what is actually happening.
There is a further problem: the evidence has not represented everyone equally. A 2025 systematic review of research involving women examined 62 studies published from 2020 to 2024. The authors found substantial methodological gaps, including the limited number of studies focused exclusively on women.
Much of that literature uses cross-sectional surveys and nonclinical samples. These studies can identify associations, but they cannot establish why a difficulty developed. Nor should findings drawn from mainly male samples become assumptions about every woman's experience.
The 2026 interdisciplinary review of CSBD and problematic pornography use also identifies important gaps involving women, gender-diverse people and populations outside the settings that dominate existing research. An inclusive vocabulary is welcome; an inclusive evidence base takes more than a change of name.
Disability, medication and the right to respectful sexual healthcare
For disabled people, conversations about sex can begin with somebody else's assumptions: that sexual activity is irrelevant, that privacy is optional, or that any expression of desire is a problem to manage. The WHO and UNFPA's guidance on sexual and reproductive health and disability starts from a more useful position: disabled people have the same sexual and reproductive health needs as other people, and face barriers to meeting them.
That principle has practical consequences here. A person should be able to describe pleasure, distress or changes in desire without their disability being used to explain everything away. They should also have the opportunity to speak privately, with communication support they choose where needed.
August Pritchett's account of being left out of sex education as a disabled student shows what exclusion can look like long before an adult reaches a clinic. Access to clear information about bodies, relationships and consent should not depend on whether someone else expects you to have a sex life.
A change after medication deserves a medication review
Sometimes a change in sexual behaviour is related to treatment or another health condition. Dopamine agonists used for Parkinson's disease can cause impulse-control difficulties, including hypersexuality. NICE recommends discussing these risks and seeking specialist advice before changing treatment when a problematic impulse-control disorder develops.
If a marked change began after starting or changing medication, tell the prescribing clinician. Do not stop or reduce Parkinson's medication on your own. A medication-related effect requires a treatment review; attaching a shame-laden label to the person does not address it.
Assessment also considers mood episodes, neurological conditions and substance effects. The timing matters. Sexual behaviour occurring only during mania, or directly attributable to a medicine, needs to be understood in that context rather than automatically assigned a separate CSBD diagnosis.
Access needs belong in the appointment
It is reasonable to ask for questions in writing, an interpreter, a quieter appointment, additional time or an accessible room. You can ask how confidentiality works if a support person accompanies you. A clinician should explain what they are assessing in language you can use, rather than leave you to interpret a loaded label alone.
Respectful care holds two things together: sexual autonomy and the possibility that someone needs help. Taking distress seriously should not require treating disabled people's sexuality as inherently dangerous, excessive or absent.
When to seek support, and what help can involve
You can ask for help if sexual thoughts or behaviour feel difficult to manage, cause distress or interfere with everyday life. You do not have to wait six months, prove a diagnosis or find the perfect terminology before making an appointment. A GP, primary-care clinician or qualified mental-health or sexual-health professional can be a starting point.
For an appointment, it may help to write down what has changed, roughly when it began, what consequences worry you and any recent changes in medication, sleep or mood. This is a way to communicate your concerns, not an invitation to monitor every thought or repeatedly test yourself.
Useful questions to ask include:
- What makes you think this is CSBD, and what other explanations are you considering?
- How will we distinguish loss of control from shame or a difference in sexual values?
- What treatment goals would make everyday life better for me?
- How will my disability, medication and access needs be included in the plan?
What the treatment evidence can tell us
Research offers reasons for cautious optimism, alongside substantial limits. A 2025 meta-analysis of psychotherapy for problematic pornography use brought together 20 studies involving 2,021 participants. It found benefits from psychological interventions, with cognitive behavioural therapy and acceptance and commitment therapy among the most studied approaches.
However, the authors identified risks of bias, and problematic pornography use is only one part of the wider research on sexual behaviour. These results should not be stretched into a claim that pornography use itself is pathological, or that one treatment is proven for everyone with CSBD.
The 2026 interdisciplinary review likewise describes a developing treatment literature with gaps in rigorous trials, diverse samples and longer follow-up. Treatment needs to fit the person, including other mental-health difficulties and the circumstances around the behaviour. The aim should be improved wellbeing and control, with a satisfying sexual life where desired, rather than an automatic prescription of abstinence.
Evidence for medication is more limited. A systematic review published in 2024 found only 13 pharmacological studies involving 141 participants, of whom just one was female. Such a small and uneven evidence base cannot support confident promises about a drug that will “fix” the problem. Medication decisions belong in an individual clinical discussion.
MC Cross's essay on living with behaviour they describe as sex addiction offers a different kind of knowledge: what it can feel like to seek understanding while confronting stigma. Personal accounts and clinical research serve different purposes. Both can make the conversation more humane when their roles are clear.
A better question than “Am I a nymphomaniac?”
Ask what is happening, what choices feel available and what support would help. Those questions allow room for a person who enjoys a lot of sex, a person frightened by unwanted thoughts, a person experiencing a medication effect and a person whose behaviour has become difficult to control. One loaded word cannot do that work.
The history of nymphomania asks us to be alert to the power of a diagnosis. Current knowledge asks us to be precise about when a diagnosis is warranted. People deserve sexual freedom, consent, privacy and care that takes their concerns seriously. None of those should have to be traded for the others.
Explore more in Relationships, Sex & Family.
Sources and editorial history
About this revision: Taryn Cain's original “Nymphomania and hypersexuality in women and men” was published by Wellcome Collection on 24 April 2015. This URevolution adaptation was first published on 24 December 2022. The present version has been substantially revised and expanded by Brendan McDonald, Editor, with updated diagnostic information, research and disability-related context. It builds on an earlier URevolution adaptation. New research and editorial interpretation should not be understood as Taryn Cain's or Wellcome Collection's endorsement.
The source article is adapted under Creative Commons Attribution 4.0 International. Changes include rewriting and restructuring the text, adding sources and removing earlier illustrations. Image rights are separate from the text licence.
This article provides general information and has not been independently medically reviewed. It cannot diagnose an individual.
- World Health Organization. ICD-11: Compulsive sexual behaviour disorder, 6C72. 2026-01 release.
- Kraus SW and colleagues. Compulsive sexual behaviour disorder in the ICD-11. World Psychiatry, 2018. DOI: 10.1002/wps.20499.
- Briken P and colleagues. Assessment and treatment of compulsive sexual behavior disorder: a sexual medicine perspective. Sexual Medicine Reviews, 2024. DOI: 10.1093/sxmrev/qeae014.
- Kowalewska E, Szumska I and Lew-Starowicz M. Expanding the Lens: A Systematic Review of the Latest Research on Compulsive Sexual Behavior and Problematic Pornography Use among Women. Current Addiction Reports, 2025. DOI: 10.1007/s40429-025-00674-3.
- Ince C and colleagues. Compulsive sexual behavior disorder (CSBD) and problematic pornography use (PPU): A comprehensive, interdisciplinary, and expert-informed narrative review with suggested future directions. Journal of Behavioral Addictions, 2026. DOI: 10.1556/2006.2025.00337.
- López-Pinar C, Esparza-Reig J and Bőthe B. Psychotherapy for problematic pornography use: A comprehensive meta-analysis. Journal of Behavioral Addictions, 2025.
- Borgogna NC and colleagues. No Magic Pill: A Systematic Review of the Pharmacological Treatments for Compulsive Sexual Behavior Disorder. The Journal of Sex Research, 2024; first published online in 2023. DOI: 10.1080/00224499.2023.2282619.
- National Institute for Health and Care Excellence. Parkinson's disease in adults (NG71), recommendations on impulse-control disorders.
- World Health Organization and UNFPA. Promoting sexual and reproductive health for persons with disabilities, 2009. Foundational rights and access guidance.
- Berrios GE. Classic Text No. 66: “Madness from the Womb”. History of Psychiatry, 2006. Historical analysis of the construction of nymphomania; abstract consulted. DOI: 10.1177/0957154X06065699.
